内容摘要：WASHINGTON (AP) — President Donald Trump is tapping Dr. Casey Means, a physician-turned-wellness influencer with close ties to Health and Human Services Secretary

WASHINGTON (AP) — President Donald Trump is tapping Dr. Casey Means, a physician-turned-wellness influencer with close ties to Health and Human Services Secretary

Being relatable is valuable for Black women, who may distrust the health care system, Jackson said. Plus, knowing the community makes it possible to work closely with other local agencies to meet people’s needs.Denise Jones, who enrolled in Healthy Start in February, has struggled with anxiety, depression and drug addiction, but has been sober since April.

In mid-July, baby items filled her room — a crib, a bassinet, tiny clothes hanging neatly in a closet — in anticipation of her child’s arrival. Jones, 32, flipped through a baby book, pointing to a sonogram of her son Levi, who would be born within a couple of weeks.She said she feels healthy and blessed by the help she’s gotten from Healthy Start and Madonna House, a transitional living program run by Catholic Charities of Eastern Oklahoma.“I have professionals that are working with me and give me support. I didn’t have that with my other pregnancies,” she said. “I’m at one with my baby and I’m able to focus.”

Associated Press data journalist Nicky Forster in New York contributed to this report.This is the second story in a two-part series examining how the United States could curb deaths from pregnancy and childbirth.

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Across the U.S., programs at all levels of government — federal, state and local — are striving to reduce maternal mortality and erase the racial gap.and identify patients who may

that can modestly slow the memory-destroying disease.The test can aid doctors in determining whether a patient’s memory problems are due to Alzheimer’s or a number of other medical conditions that can cause cognitive difficulties. The Food and Drug Administration cleared it for patients 55 and older who are showing early signs of the disease.

More than 6 million people in the United States and millions more around the world have Alzheimer’s, the most common form of dementia.The new test, from Fujirebio Diagnostics, Inc., identifies a sticky brain plaque, known as beta-amyloid, that is a key marker for Alzheimer’s. Previously, the only FDA-approved methods for detecting amyloid were invasive tests of spinal fluid or expensive PET scans.